Centiva Capital’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-36,554	Closed	-$280K	–	1596
2023 Q3	$280K	Buy	+36,554	New	+$280K	0.01%	790
2023 Q2	–	Sell	-13,618	Closed	-$90.8K	–	1482
2023 Q1	$90.8K	Buy	+13,618	New	+$90.8K	﹤0.01%	959